The Impact of Suboxone’s Market Exclusivity on Cost of Opioid Use Disorder Treatment

BACKGROUND: Buprenorphine-naloxone is an essential part of the response to opioid poisoning rates in North America. Manipulating market exclusivity is a strategy manufacturers use to increase profitability, as evidenced by Suboxone in the USA. OBJECTIVE: To investigate excess costs of buprenorphine-...

Descripción completa

Detalles Bibliográficos
Autores principales: McGee, Meghan, Chiu, Kellia, Moineddin, Rahim, Sud, Abhimanyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119248/
https://www.ncbi.nlm.nih.gov/pubmed/36652186
http://dx.doi.org/10.1007/s40258-022-00787-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119248/
https://www.ncbi.nlm.nih.gov/pubmed/36652186
http://dx.doi.org/10.1007/s40258-022-00787-0

Ejemplares similares